top of page

RBC Global Healthcare Conference: With clinical validation that has been seen on the target from a large pharma, Contineum has moved its LPA1R antagonist aggressively into the clinic for IPF

  • 48 minutes ago
  • 1 min read

CEO Carmine Stengone describes the target, and why he believes Contineum has a best-in-class asset. Plus, background on a key upcoming readout for the company's M1R antagonist that partner JNJ will have in major depressive disorder later this year.





Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

​

​Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page